Read more

Cryomicroneedles for Transdermal Cell, Drug Delivery - Anti-aging and Diabetes Treatment

Our main business


Our cryomicroneedle (CMN) is an innovative drug-device combination product which allows effective storage, transportation, and in situ delivery of living cells, biologics and drugs.

Company profile

Greater Bay Biotechnology (GBBT) is a business supported by City University of Hong Kong (CityU) HK Tech 300 program, HKSTP Ideation program and HKSAR Government Innovation and Technology Fund.

GBBT focuses on the research, development and commercialisation of transdermal drug and cell delivery technology for the treatment of both local and systemic diseases.

Multi-award winning

The CMN research was published at Nature Biomedical Engineering in May 2021

Lastest News

GBBT interviewed on TVB 

An interview based on the cryomicroneedle (CMN) technology led by Dr. Xu Chenjie at the City University of Hong Kong. It is the world's first microneedle......

Invited to attend the "2023 International Bay Area Summit" 

to share

“Connection Hong Kong innovative Biomedical Technology with Greater Bay Area's Industry and Contribute to Society”

For more information 

Follow our public account on WeChat for more information.

Let us help you better understand your needs.

Stay close to us

Leave us your contact

Be the first to know about the latest offers and scientific analysis

Greater Bay Biotechnology Limited

Address:Flat 2304, 23/F, Ho King Commercial Centre, 2-16 Fa Yuen Street, Kowloon, Hong Kong

Phone number:(+852) 94702805

Copyright 2021 All rights reserved. Greater Bay Biotechnology Limited

Technical Support: 97建站 | Admin Login
seo seo